2025 Tutorial on Neoplastic Hematopathology (Slides only)

Continuing in the tradition of 40+ years of tutorials, the 2025 course is designed to update physicians on the latest advances in neoplastic hematopathology. It will be conducted under the direction of Dr. Daniel A. Arber at the Renaissance Phoenix Downtown Hotel from January 20–24, 2025. The program will consist of lectures, case presentations, and discussions designed to provide pathologists, pathologists-in-training, and medical oncologists/ hematologists with an in-depth discussion of diagnostic problems that arise in neoplastic hematopathology.

Target Audience

This activity is designed for pathologists and other healthcare professionals dedicated to the diagnosis of hematological malignancies.

Learning Objectives

At the conclusion of this activity, participants will be able to:

Identify how to evaluate and respond to diagnostic problems that arise in neoplastic hematopathology;

State how to utilize recent advances in the classification of hematopoietic tumors;

Discuss how to interpret and apply immunologic and molecular genetic findings in the diagnosis of neoplastic hematologic disease;

Describe how to implement the most recent classification of hematologic neoplasms;

Recall new discoveries that might impact future classifications of hematologic neoplasms;

Understand the prognostic and therapeutic significance of new molecular genetic markers of these tumors.

Additional information

ACGME/ABMS Core Competencies:

Medical Knowledge
Practice-based Learning and Improvement

Program

Monday, January 20

8:00 AM
Introductory Remarks
Daniel Arber, MD

Morning Session
Chairperson: Daniel Arber, MD

8:15 AM
Normal Lymph Nodes and Reactive Hyperplasias
Rebecca King, MD

9:30 AM
Introduction to the Classification of Lymphoma
James Cook, MD

10:15 AM
BREAK

10:30 AM
Monoclonal B Lymphocytosis, Chronic Lymphocytic Leukemia and Related B-Cell Leukemias
Kathy Foucar, MD

11:45 AM
Questions

12:00 PM
LUNCH

Afternoon Session
Chairperson: Kathy Foucar, MD

1:30 PM
Chronic T/NK Cell Leukemias
Kathy Foucar, MD

2:00 PM
Lymphoplasmacytic Lymphoma and Nodal and Extranodal Marginal Zone Lymphoma
James Cook, MD, PhD

3:00 PM
Questions

3:15 PM
BREAK

3:30 PM
Mantle Cell Lymphoma, Follicular Lymphoma and Variants
Rebecca King, MD

4:30 PM
Questions

4:45 PM-
5:30 PM
Case Presentations
Rebecca King, MD, James Cook, MD, PhD &
Kathy Foucar, MD

Tuesday, January 21

Morning Session
Chairperson: Michael Borowitz, MD

8:00 AM
Peripheral T Cell Lymphoma and Anaplastic Large Cell Lymphoma
Elaine Jaffe, MD

9:30 AM
Questions

9:45 AM
BREAK

10:00 AM
Acute Lymphoblastic Leukemia/Lymphoma and Acute Leukemias of Ambiguous Lineage
Michael Borowitz, MD

11:30 AM
Questions

11:45 AM
Case Presentations
Michael Borowitz, MD &
Elaine Jaffe, MD

12:15 PM
LUNCH

Afternoon Session
Chairperson: Rebecca King, MD

1:45 PM
Diffuse, Aggressive B Cell Lymphomas
Rebecca King, MD

2:45 PM
Questions

3:00 PM
BREAK

3:15 PM
Lymphoma Diagnosis: A Clinician’s Perspective
Javier Munoz, MD, MBA

4:15 PM
Questions

4:30 PM-
5:00 PM
Case Presentations
Rebecca King, MD

Wednesday, January 22

Morning Session
Chairperson: Jonathan Said, MD

8:00 AM
Splenic Tumors
Daniel Arber, MD

9:00 AM
Hodgkin Lymphoma
Amy Chadburn, MD

10:00 AM
Questions

10:15 AM
BREAK

10:30 AM
Immunodeficiency-and Viral-Associated Lymphoproliferations
Jonathan Said, MD

11:45 AM
Questions

12:00 PM
LUNCH

Afternoon Session
Chairperson: Amy Chadburn, MD

1:30 PM
Histiocytic Disorders
Amy Chadburn, MD

2:45 PM
Questions

3:00 PM
BREAK

3:15 PM
Cutaneous Lymphomas
Jonathan Said, MD

4:15 PM
Questions

4:30 PM-
5:00 PM
Case Presentations
Daniel Arber, MD
Jonathan Said, MD &
Amy Chadburn, MD

Thursday, January 23

Morning Session
Chairperson: Adam Bagg, MD

8:00 AM
Introduction to the Classification of Myeloid Neoplasms and Acute Leukemia
Daniel Arber, MD

8:45 AM
Chronic Myeloid Leukemia
Adam Bagg, MD

9:30 AM
Questions

9:45 AM
BREAK

10:00 AM
BCR: ABL1–negative Myeloproliferative Neoplasms
Attilio Orazi, MD

11:00 AM
Eosinophilic Disorders
Adam Bagg, MD

11:45 AM
Questions

12:00 PM
LUNCH

Afternoon Session
Chairperson: Robert Lorsbach, MD

1:30 PM
Clonal Cytopenias and Myelodysplastic Syndrome
Robert Hasserjian, MD

2:45 PM
Pediatric and Germline Predisposition Syndromes
Robert Lorsbach, MD

3:30 PM
Questions

3:45 PM
BREAK

4:00 PM
Plasma Cell Neoplasms
Robert Lorsbach, MD, PhD

4:45 PM
Questions

5:00 PM-
5:45 PM
Case Presentations
Robert Hasserjian, MD & Robert Lorsbach, MD, PhD

Friday, January 24

Morning Session
Chairperson: Daniel Arber, MD

8:00 AM
Myelodysplastic/Myeloproliferative Neoplasms
Attilio Orazi, MD

9:00 AM
Acute Myeloid Leukemias
Daniel Arber, MD

10:00 AM
Questions

10:15 AM
BREAK

10:30 AM
Mastocytosis
Attilio Orazi, MD

11:15 AM
Case Presentations
Daniel Arber, MD & Attilio Orazi, MD

11:45 AM
Questions

12:00 PM-
12:30 PM
Concluding Remarks